These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26348846)

  • 1. Prioritizing human pharmaceuticals for ecological risks in the freshwater environment of Korea.
    Ji K; Han EJ; Back S; Park J; Ryu J; Choi K
    Environ Toxicol Chem; 2016 Apr; 35(4):1028-36. PubMed ID: 26348846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranking and prioritizing pharmaceuticals in the aquatic environment of China.
    Li Y; Zhang L; Liu X; Ding J
    Sci Total Environ; 2019 Mar; 658():333-342. PubMed ID: 30579191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
    Aubakirova B; Beisenova R; Boxall AB
    Integr Environ Assess Manag; 2017 Sep; 13(5):832-839. PubMed ID: 28120523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals.
    Perazzolo C; Morasch B; Kohn T; Magnet A; Thonney D; Chèvre N
    Environ Toxicol Chem; 2010 Aug; 29(8):1649-57. PubMed ID: 20821616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset.
    Berninger JP; LaLone CA; Villeneuve DL; Ankley GT
    Environ Toxicol Chem; 2016 Apr; 35(4):1007-20. PubMed ID: 25772004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
    Ferrari B; Mons R; Vollat B; Fraysse B; Paxéus N; Lo Giudice R; Pollio A; Garric J
    Environ Toxicol Chem; 2004 May; 23(5):1344-54. PubMed ID: 15180389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
    Zuccato E; Castiglioni S; Fanelli R
    J Hazard Mater; 2005 Jul; 122(3):205-9. PubMed ID: 15967275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.
    Zuccato E; Castiglioni S; Fanelli R; Reitano G; Bagnati R; Chiabrando C; Pomati F; Rossetti C; Calamari D
    Environ Sci Pollut Res Int; 2006 Jan; 13(1):15-21. PubMed ID: 16417127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing pharmaceuticals based on environmental risks in the aquatic environment in China.
    Guo J; Liu S; Zhou L; Cheng B; Li Q
    J Environ Manage; 2021 Jan; 278(Pt 1):111479. PubMed ID: 33126192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
    Mansour F; Al-Hindi M; Saad W; Salam D
    Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
    Christensen AM; Markussen B; Baun A; Halling-Sørensen B
    Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and risk of pharmaceuticals in freshwater systems are related to the population density and the livestock units in Iberian Rivers.
    Osorio V; Larrañaga A; Aceña J; Pérez S; Barceló D
    Sci Total Environ; 2016 Jan; 540():267-77. PubMed ID: 26170112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
    Roos V; Gunnarsson L; Fick J; Larsson DG; Rudén C
    Sci Total Environ; 2012 Apr; 421-422():102-10. PubMed ID: 22361586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
    Donnachie RL; Johnson AC; Sumpter JP
    Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical residues in streams near concentrated animal feeding operations of Korea - Occurrences and associated ecological risks.
    Kim B; Ji K; Kim C; Kang H; Lee S; Kwon B; Kho Y; Park K; Kim K; Choi K
    Sci Total Environ; 2019 Mar; 655():408-413. PubMed ID: 30472642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.
    Al-Khazrajy OS; Boxall AB
    Environ Sci Pollut Res Int; 2016 Aug; 23(15):15712-26. PubMed ID: 27137195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France.
    Minguez L; Pedelucq J; Farcy E; Ballandonne C; Budzinski H; Halm-Lemeille MP
    Environ Sci Pollut Res Int; 2016 Mar; 23(6):4992-5001. PubMed ID: 25292303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritization of pharmaceuticals in water environment in China based on environmental criteria and risk analysis of top-priority pharmaceuticals.
    Li Y; Zhang L; Ding J; Liu X
    J Environ Manage; 2020 Jan; 253():109732. PubMed ID: 31698331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of metabolites in the environmental risk assessment of pharmaceuticals consumed by human.
    Han EJ; Lee DS
    Sci Total Environ; 2017 Aug; 592():600-607. PubMed ID: 28318699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea.
    Kim Y; Choi K; Jung J; Park S; Kim PG; Park J
    Environ Int; 2007 Apr; 33(3):370-5. PubMed ID: 17223195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.